Published in Curr Drug Deliv on May 01, 2011
In vivo gene delivery by nonviral vectors: overcoming hurdles? Mol Ther (2012) 1.59
Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA. ACS Nano (2012) 1.30
Progress in gene therapy for neurological disorders. Nat Rev Neurol (2013) 1.22
Overcoming nonviral gene delivery barriers: perspective and future. Mol Pharm (2013) 1.10
DNA micelle flares for intracellular mRNA imaging and gene therapy. Angew Chem Int Ed Engl (2013) 1.07
Non-viral gene delivery via membrane-penetrating, mannose-targeting supramolecular self-assembled nanocomplexes. Adv Mater (2013) 0.98
Gene delivery to bone. Adv Drug Deliv Rev (2012) 0.93
Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation. Biomaterials (2014) 0.92
Generation of a focused poly(amino ether) library: polymer-mediated transgene delivery and gold-nanorod based theranostic systems. Theranostics (2012) 0.89
Functional nanostructures for effective delivery of small interfering RNA therapeutics. Theranostics (2014) 0.85
Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA. Pharmaceutics (2012) 0.83
Suppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1. Int J Nanomedicine (2012) 0.82
BMP2 gene delivery to bone mesenchymal stem cell by chitosan-g-PEI nonviral vector. Nanoscale Res Lett (2015) 0.81
Gene therapy for bone engineering. Front Bioeng Biotechnol (2015) 0.81
Assessment of the evolution of cancer treatment therapies. Cancers (Basel) (2011) 0.80
Integration of drug, protein, and gene delivery systems with regenerative medicine. Drug Deliv Transl Res (2015) 0.79
Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy. Int J Nanomedicine (2013) 0.78
Investigation of the cytokine response to NF-κB decoy oligonucleotide coated polysaccharide based nanoparticles in rheumatoid arthritis in vitro models. Arthritis Res Ther (2015) 0.78
Anchoring of self-assembled plasmid DNA/anti-DNA antibody/cationic lipid micelles on bisphosphonate-modified stent for cardiovascular gene delivery. Int J Nanomedicine (2013) 0.78
Induction of osteogenic differentiation of stem cells via a lyophilized microRNA reverse transfection formulation on a tissue culture plate. Int J Nanomedicine (2013) 0.77
Genetic manipulation for inherited neurodegenerative diseases: myth or reality? Br J Ophthalmol (2016) 0.77
Nanoparticles carrying neurotrophin-3-modified Schwann cells promote repair of sciatic nerve defects. Neural Regen Res (2013) 0.77
Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis. Regen Eng Transl Med (2016) 0.76
Gene delivery from supercharged coiled-coil protein and cationic lipid hybrid complex. Biomaterials (2014) 0.75
Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA. Drug Des Devel Ther (2017) 0.75
Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications. J Control Release (2015) 0.75
Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes. Beilstein J Nanotechnol (2015) 0.75
Carrier-free Gene Silencing by Amphiphilic Nucleic Acid Conjugates in Differentiated Intestinal Cells. Mol Ther Nucleic Acids (2016) 0.75
Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells. Mol Pharm (2016) 0.75
Generation of stable cell line by using chitosan as gene delivery system. Cytotechnology (2015) 0.75
Using magnetic nanoparticles for gene transfer to neural stem cells: stem cell propagation method influences outcomes. J Funct Biomater (2015) 0.75
Down-regulation of Noggin and miR-138 coordinately promote osteogenesis of mesenchymal stem cells. J Mol Histol (2017) 0.75
Protein based therapeutic delivery agents: Contemporary developments and challenges. Biomaterials (2017) 0.75
Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine (2002) 1.34
Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol (2004) 1.16
Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Mol Ther (2003) 0.97
Topical non-invasive gene delivery using gemini nanoparticles in interferon-gamma-deficient mice. Eur J Pharm Biopharm (2007) 0.89
In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes. J Gene Med (2005) 0.88
Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies. Nanomedicine (Lond) (2010) 0.87
Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix). J Pharm Pharmacol (2002) 0.86
Thermodynamic and aggregation properties of aza- and imino-substituted gemini surfactants designed for gene delivery. Phys Chem Chem Phys (2006) 0.85
Gemini surfactants: a new family of building blocks for non-viral gene delivery systems. Curr Gene Ther (2008) 0.83
Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles. Eur J Pharm Biopharm (2010) 0.82
Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats. Diabetes Technol Ther (2002) 0.82
Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles. J Gene Med (2007) 0.82
Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents. Curr Drug Deliv (2011) 0.82
Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma. Nanomedicine (Lond) (2012) 0.81
Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients. Int J Nanomedicine (2012) 0.81
The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization. Immunology (2002) 0.80
Hyperforin promotes mitochondrial function and development of oligodendrocytes. J Neurochem (2011) 0.80
Investigation of complexes formed by interaction of cationic gemini surfactants with deoxyribonucleic acid. Phys Chem Chem Phys (2007) 0.80
Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability. Mol Pharm (2013) 0.79
Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs. AAPS J (2005) 0.79
Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration. Curr Drug Deliv (2004) 0.78
Non-invasive immunization on the skin using DNA vaccine. Curr Drug Deliv (2006) 0.78
Synthesis, characterization, and use of asymmetric pyrenyl-gemini surfactants as emissive components in DNA-lipoplex systems. Langmuir (2007) 0.77
New technology and clinical applications of nanomedicine: highlights of the second annual meeting of the American Academy of Nanomedicine (Part I). Nanomedicine (2006) 0.77
Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.76
Protection of Neonatal Broiler Chickens Following in ovo Delivery of Oligodeoxynucleotides Containing CpG Motifs (CpG-ODN) Formulated with Carbon Nanotubes or Liposomes. Avian Dis (2015) 0.76
Enhancement of immunoprotective effect of CpG-ODN by formulation with polyphosphazenes against E. coli septicemia in neonatal chickens. Curr Drug Deliv (2009) 0.76
In vivo sustained dermal delivery and pharmacokinetics of interferon alpha in biphasic vesicles after topical application. Eur J Pharm Biopharm (2013) 0.75
Nanotechnology enables superior medical therapies. Curr Drug Deliv (2011) 0.75
Evidence for lymphatic transport of insulin by topically applied biphasic vesicles. J Pharm Pharmacol (2003) 0.75
The 4th Annual Meeting of the American Society for Nanomedicine. J Neuroimmune Pharmacol (2014) 0.75
Synthesis and solution properties of gemini surfactants containing oleyl chains. Phys Chem Chem Phys (2005) 0.75
Biphasic lipid vesicles as a subcutaneous delivery system for protein antigens and CpG oligonucleotides. Curr Drug Deliv (2006) 0.75